What are the appropriate dosing orders for hyoscyamine (including immediate‑release and extended‑release formulations) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hyoscyamine Dosing Orders

For adults and children ≥12 years, order hyoscyamine sulfate oral solution 1-2 mL (0.125-0.25 mg) every 4 hours as needed, not exceeding 12 mL (1.5 mg) in 24 hours; for children 2 to <12 years, dose 0.25-1 mL (0.03125-0.125 mg) every 4 hours based on body weight, not exceeding 6 mL (0.75 mg) in 24 hours; for infants <2 years, dose 4-8 drops (0.01-0.01375 mg) every 4 hours based on specific body weight, with maximum daily doses ranging from 24-48 drops depending on weight. 1

Adult and Adolescent Dosing (≥12 years)

Immediate-Release Formulations

Oral Drops:

  • Dose: 1-2 mL every 4 hours or as needed
  • Maximum: 12 mL in 24 hours
  • Each mL contains 0.125 mg hyoscyamine sulfate 1

Elixir:

  • Dose: 1-2 teaspoonfuls (5-10 mL) every 4 hours or as needed
  • Maximum: 12 teaspoonfuls in 24 hours 1

Extended-Release Formulations

Extended-release hyoscyamine has demonstrated clinical utility in specific populations, with approximately 68.5% response rates for high bowel frequency and 61.5% for abdominal pain in pouch patients, with 37.8% of patients continuing therapy beyond 3 years 2

Pediatric Dosing (2 to <12 years)

Weight-Based Dosing with Elixir:

  • 10 kg (22 lb): ¼ teaspoonful (1.25 mL) every 4 hours
  • 20 kg (44 lb): ½ teaspoonful (2.5 mL) every 4 hours
  • 40 kg (88 lb): ¾ teaspoonful (3.75 mL) every 4 hours
  • 50 kg (110 lb): 1 teaspoonful (5 mL) every 4 hours
  • Maximum: 6 teaspoonfuls in 24 hours 1

Oral Drops Alternative:

  • Dose: 0.25-1 mL every 4 hours or as needed
  • Maximum: 6 mL in 24 hours 1

Infant Dosing (<2 years)

Critical weight-based dosing using oral drops - measure very carefully with calibrated dropper:

Body Weight Dose (every 4 hours) Maximum in 24 hours
3.4 kg (7.5 lb) 4 drops (0.08 mL = 0.01 mg) 24 drops
5 kg (11 lb) 5 drops (0.14 mL = 0.0175 mg) 30 drops
7 kg (15 lb) 6 drops 36 drops
10 kg (22 lb) 8 drops 48 drops

1

Dropper Calibration Reference

The provided dropper has specific markings:

  • 3 drops = 0.08 mL = 0.01 mg hyoscyamine sulfate
  • 4 drops = 0.11 mL = 0.01375 mg
  • 5 drops = 0.14 mL = 0.0175 mg
  • 0.25 mL mark = 0.25 mL = 0.03125 mg 1

Special Pediatric Indication: Anticholinesterase Poisoning

For children with anticholinesterase or nerve gas poisoning:

  • Initial IV dose: 0.05 mg/kg (up to adult dose of 2-5 mg)
  • May double dose and repeat every 10-20 minutes as needed to achieve anticholinergic effect (atropinization) and dry pulmonary secretions
  • Large doses may be required 3

Critical Prescribing Considerations

Dosage adjustment: Adjust according to condition severity and symptom response 1

Measurement precision: Use calibrated droppers or measuring devices - this is particularly critical for infants where small volume errors translate to significant dose variations 1

Formulation concentration awareness: Different formulations have different concentrations - oral drops contain 0.125 mg/mL while elixir formulations may vary 1

Maximum daily limits: Strictly adhere to maximum daily doses, which are age-dependent and designed to prevent anticholinergic toxicity 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.